Skip to main content

2024 – Liana Tsikitis

Vassiliki Liana Tsikitis MD MCR MBA 2022 James IV Travelling Fellow

I am deeply grateful for the privilege of being selected as the James IV Surgical Association Traveling Fellow from the United States for 2022. I want to particularly thank Dr. John Hunter for his sponsorship and support for this unique opportunity. Due to the COVID pandemic I delayed my travel experience to the spring of 2023 and summer of 2024.

My travels took me across the United Kingdom in the summer of 2023, visiting cities including London, Manchester Leeds, and Edinburgh. In the spring of 2024, I embarked on the second leg of my fellowship, traveling to Australia (Melbourne and Sydney) and New Zealand (Auckland). This schedule allowed me to align part of my trips with my family’s time off, which added to the experience as I made lifelong connections not only with colleagues but also with their families.

My primary goal as a James IV Traveling Fellow was to observe how surgeons in different countries, with varying healthcare systems and cultural and political challenges, assess the quality of surgical care and promote the highest patient care standards. As a colorectal surgeon, I also aimed to learn how the ever-evolving paradigms of colorectal cancer are practiced around the globe and how other providers and healthcare systems have safely implemented modern technologies. What I gained from the experience far exceeded these expectations. I had the opportunity to meet and learn from a wide array of professionals including colorectal surgeons, health care administrators and basic science researchers, attend the annual meeting of the Association of Coloproctology of Great Britain & Ireland. I was fortunate that my family was able to join me for significant portions of the trip and listened as I enthusiastically retold highlights from the morning while sightseeing in the afternoons and evenings. Sharing these experiences with my family made the journey truly unforgettable. The people I met and the insights I gained are impossible to fully capture in a few pages, but I will describe the highlights of my learnings.

 

 

UK Trip (London, Manchester, Leeds, and Edinburgh)

My choice to go to the UK was multifaceted. Serving as the head of a large multi-sectioned general surgery division, I have encountered the challenges of the current healthcare landscape in the United States. Nursing turnover and premium labor costs were the reality pre-COVID and became exacerbated to the point of near collapse by the COVID pandemic. We also know that high healthcare spending does not translate to best patient care. I

 

wanted to gain exposure to the practice of surgery in a universal health care system and

identified the UK’s National Health Service system as an excellent case study.

When I arrived in London, all the hospitals I had pre-arranged to visit were facing a strike threat from the house staff workforce. Although in 2019 the long-term plan of the NHS seemed to want to address the workforce problems, emphasizing “that the performance of any health care system ultimately depends on its people”, it failed to recognize that investment on their workforce incentivization, productivity, culture and advancement was instrumental. The trainees that I spoke to when I visited were failing to see the return on their investment with meager compensation that led to their difficulties “making ends meet”. During my second day in London, while visiting with Professor Ara Darzi, I attended the Hamlyn Symposium on Medical Robotics. The keynote speaker was Dr. Tim Ferris, the National Director of Transformation NHS England, and NHS Improvement. He discussed the government’s increased funding for the NHS to 3.4% from the previous 2.2 % and presented the updated NHS Five Year Forward View. He discussed how increasing the supply to meet the demand is not adequate to address workforce shortages. He discussed a multipronged approach to address the current workforce pressures including the expansion of clinical placements, establishing new routes into nursing and other disciplines, international recruitment, a set of incentives for hard-to-recruit geographies, and importantly “flexible rostering” and funding for continuing professional development to support current staff.

The idea of bringing agency and directing funding to local areas provoked my thinking about the possibility of state health care systems and reconfiguring the healthcare system according to the needs of the community as strategies to alleviate health inequalities.

Although the Forward View sought to separate patient care between family doctors and hospitals, between physical and mental health, and between health and social care, I witnessed a system with overwhelmed GPs each addressing hundreds of patients, unable to attend to them in a timely manner unless their patient was facing a significant health threat.

During my week in London my generous hosts in the city of London included Drs. Jamie Murphy, Ara Darzi, Amyn Haji and Simon Buczacki. I spent the first day observing cases with Dr. Murphy and his partner Dr. Chet Bhan. The opportunity to spend time together led to a fruitful collaboration and the three of us jointly organized sessions for the surgical meetings of the Society of Surgeons of the Alimentary Tract in Washington DC and the International Society for Digestive Surgery in Kuala Lumpur. The second day, I met with Professor Darzi and attended the Hamlyn Symposium of Robotics where innovative robotic platforms were introduced and discussed. Intuitive dominates the market in the US and the

 

opportunity for me to be exposed to other robotic platforms was encouraging for what the future may hold in the US. The third day I visited with Dr. Amyn Haji, who is the clinical lead for colorectal surgery and endoscopy at King’s College Hospital. I was impressed with the teaching facility and the curriculum he has developed on advanced endoscopic procedures. His trainees were gastroenterology fellows from all over the UK and Australia. I was able to spend the day observing, and later attending a state-of-the-art surgical endoscopy course that he organized during the ACPGBI meeting that took place the following week in Manchester.

I was impressed by the collaborative spirit between gastroenterology and colorectal surgery units. Based on the introduction and person-to-person time made possible by my James IV fellowship, I was privileged to invite Dr. Haji to be a speaker at the combined clinical symposium during Digestive Disease Week 2024 in Washington DC, where they spoke on the management of malignant colorectal polyps and the role of endoscopic submucosal dissection. I consider myself fortunate to have established long-lasting collaborations with Drs. Murphy, Bhan and Haji and I am excited for the next projects we will work on together.

The next couple of days I spent in Cambridge visiting a research colleague with whom I had previously collaborated, Dr. Sarah Bohndiek, based at Corpus Christi College. Together we obtained a CRUK grant on the role of hyperspectral endoscopy (HySE) system and its ability to differentiate malignant versus benign polyps of the colon and rectum. It was a wonderful visit that coincided with the college’s graduation; it was a special treat to attend the graduation ceremony.

The next day I visited Oxford and met with Professor Simon Buczacki and the colorectal surgery team including Ms. Kat Baker, Mr. Bruce George, Mr. David James, and Mr. Nicholas Symon. We had a round table discussion on total neoadjuvant treatment for locally advanced rectal cancer and I attended their monthly mortality and morbidity conference. I was impressed with Dr. Buczacki’ s basic science research on genetic and non-genetic clonal diversity in colorectal cancer; the role of copy number variations that give rise to intratumoral heterogeneity that may partly explain how targeted chemotherapy agents for certain mutations, effective initially against the disease, lose their effectiveness overtime. This was the conclusion of my first week in the UK, focusing on London and the surrounding areas.

The next week was split between Manchester and Leeds. In Manchester I attended the ACPGBI (The Association of Coloproctology of Great Britain and Ireland) conference, where

 

I re-connected with several people I met in London, and had my initial meeting with my next hosts, Professor Peter Sagar, and Dr. Jim Tiernan with St James Hospital in Leeds.

My visit at Leeds’s internationally famous St James Hospital, where I spent three days observing complex pelvic exenteration and resection of advanced rectal and anal squamous cancers, in my mind was the epitome of where the NHS system showed how it can be an efficient and equitable health care system, providing cost effective, coordinated, and patient-centered care.

Professor Sagar has built a remarkable colorectal unit, where referrals for all advanced pelvic cancers within Great Britain and Ireland are sent, and patients receive timely multidisciplinary care. There is a colorectal management unit composed of administrative staff that process hundreds of referrals according to acuity and direct them to the right provider teams. Patients are presented in a weekly multidisciplinary board where steps of care are decided, and nurse navigators assist patients through the sequence of the treatment arms deemed necessary. What I witnessed in Leeds is a center of excellence supported by the NHS where all healthcare providers, including surgeons, physicians, and support staff with extensive experience and specialized training, all follow the latest evidence-based guidelines to provide the best possible care.

In the States we have multiple discussions during our national meetings and with our political representatives regarding the need for Centers of Excellence, though we still struggle with designation of those centers. Challenges to adopting such a model in the United States include geography, where distance between the patient’s home and hospital can be significant, and insurance provider agreements, which dictate where care can and will be received.

On a personal note, as my last stop in England, my visit to Leeds was a highlight. My family had joined me in Manchester and traveled with me on the train to Leeds. When we arrived, we discovered we happened to be staying at the hotel where the Australian national cricket team was staying while competing in The Ashes. My ten-year-old son was excited each morning when various players would ride in the elevator with him to the breakfast room.

Though unfamiliar with cricket, he was inspired to follow the scores and the matches that took place at the Headingley Cricket Grounds in Leeds.

Our next stop was Edinburgh, where I met with Professor Rowan Parks, who is currently the president of the Royal College of Surgeons. He was a wonderful host that showed my family and I around the Surgeon’s Hall Museum and shared the story of how the James the IV Travelling Fellowship started. The hospitality of Professors James Garden and Rowan Parks was unparalleled. I felt that I was among great old friends. There was a dinner for my family

 

with faculty from the University of Edinburgh, where I met Professor Malcom Dunlop, who is

an inspiring surgeon and researcher in the field of colorectal surgery.

The next day was filled with multiple research presentations from Professor Dunlop’s lab and a tour of the Western General Hospital. The colorectal unit at Western hospital is highly regarded for its academic rigor and its excellent patient-centered care and I witnessed both. During my visit I met Drs. Farhat Din, Doug Speake and Sarah Goodbrand, as well as connected with another Mayo Clinic alumnae, Dr. Danielle Collins.

The next day I visited the Royal Infirmary and Professor Garden gave me a Quaich, which is a special two-handed drinking cup that symbolizes friendship and partnership. In my short travels in Scotland, I learned how the Scottish system differs from England’s NHS. I sensed that the public and the physicians thought that the healthcare delivery was good and equitable. Although private insurance exists, the sentiment was that the NHS Scotland adequately attends to its population’s health needs.

During my Scottish week, my family and I had an opportunity to explore the cities of Edinburgh (where we enjoyed a concert by The Who at Edinburgh Castle), St. Andrews (where I scored a hole in one on The Himalayas) and Glasgow (where we toured Celtic Park and had tea and biscuits at Mckintosh’s famous Willow Tea Room), as well as enjoy a scenic drive to the north and around Loch Ness.

 

 

Australia (Melbourne, Sydney) & New Zealand (Auckland)

The second arm of my trip took me to Australia and New Zealand in March of 2024. I chose to visit this region because of family and colleagues who have moved to that part of the world, commenting on the exceptional quality of life and the health care they receive. In addition, Professor Michael Solomon’s clinical research program is world renowned, and I wanted to visit the people behind the Surgical Outcomes Research Centre (SOuRCe).

Arriving to Australia through Melbourne, I spent the first two days in the Peter MacCallum Cancer Centre hospital where I attended their multidisciplinary tumor board conferences and observed a few operations. My hosts in Melbourne were Drs. Joseph Kong, Alexander Heriot, Peter Carne and Jamie Keck, all well-known colorectal surgeons who were welcoming and generous with their time. During my week in Melbourne, I visited The Alfred, Cabrini Malvern, and St. Vincent’s hospitals. I attended their multidisciplinary GI tumor board and IBD conferences and I presented my research on the role of the gut microbiome in early colorectal neoplasia.

 

I was fascinated by the Australian Health System as well as the education of surgical trainees. One of the key characteristics is that both the public and private sectors play a key role in the funding and the provision of care under a common national framework. I was fascinated to learn that each hospital had slightly different funding stream from the federal and state government. During my discussions with Dr. Heriot from Peter Mac, I learned that each year the funding of his surgical oncology unit (encompassing all oncologic surgical specialties) is based on the past budget needs and factors in the quality of care as measured by patient outcomes. It made me think about value-based care and how CMS is currently trying to implement reimbursement with certain diagnoses and CPT codes.

In Australia they do not have national programs such as the National Surgical Quality Improvement Program (NSQIP) or the Commission on Cancer (CoC). Instead, quality is measured by patient experience surveys and clinical quality registries (most provided and run by each individual hospital). In Australia there are government-funded quality tracking agencies including the Aged Care Quality and Safety Commission that measures aged care across hospitals. I think the United States may benefit from such an entity, as a potential way to curtail the ever-rising healthcare costs of our aged population.

Through my conversations with local providers, I learned that this capitated system does not allow for potential market growth by the hospitals that are funded through the government. As an example, Dr. Heriot explained that if he received $115 million to cover the fiscal year, he could not support any additional oncologic procedures for patients with public insurance when that funding is exhausted – even if that is several months prior to the end of the budget year. I found, in this system, that the right balance was met when it comes to the reimbursement of consultants between public and private funding. Most surgical consultants in governmental funded hospitals (they are known as Visting Medical Officers VMOs) would have a limited FTE and the rest of their practice would be based on the private sector – where most of their personal funding would come.

As a cost containment strategy, the government has supported the position that citizens should have a supplementary private health insurance to control Australian Medicare costs (which have sharply risen over that past decade) and to continue providing good elective care with reasonable waiting times. Impressively, more than 50% of the population has followed this recommendation. Overall, I found that the quality of health care in Australia is high for complex cancer care and that for less acute elective care the private sector has stepped in to assure timely response. Though I find the multiple separate funding streams to the public hospitals complex, it does allow them to offer good and timely patient care.

 

The training of the surgical trainees is also significantly different from the US experience. Finishing medical school and working as a general surgical officer without having entered a formal surgical training program is the norm. The system absorbs the medical school graduates as an equivalent to a categorical US surgical resident and it may take multiple years to achieve their formal placement in a training program.

During my second week in Australia, I moved to Sydney where I spent several days at the Royal Prince Alfred (RPA) Hospital where my hosts were Professor Michael Solomon and Dr. Cherry Koh. I met a young trainee in her third year at RPA, applying for surgical residency while acting on the service in a manner consistent with a highly functional midlevel US surgical resident rounding on the wards and scrubbing in the cases. She was hopeful that she would enter the RPA surgical training program the following year as an intern.

At RPA, I had the pleasure of meeting with the Surgical Outcomes Research Centre (SOuRCe) leaders including Drs. Solomon, Koh and Steffens. The Center, where a large research team including statisticians, medical students, PhD students, and surgeons work together, is impressive and currently more than 200 research projects are underway in parallel. They have implemented an impressive prehabilitation program for their frail patients undergoing complex surgical cancer care.

On a personal note, my family joined me in Sydney for this portion of the fellowship experience. We were able to explore several charming neighborhoods, tour the famous Opera House, stroll through the Royal Botanic Gardens, and see the Socceroo’s take on Lebanon in a World Cup Qualifier match when I was not in the hospital and clinics.

Together, we traveled onto Auckland, New Zealand for the final leg of my travels, where my host was Maree Weston and the colorectal surgeons at Middlemore hospital. She and her family were delightful hosts.

 

 

In Auckland, I had the opportunity to attend and participate in the quarterly city-wide colorectal surgical journal club, where we discussed the new paradigm of locally advanced rectal cancer care with the advent of total neoadjuvant treatment. It was a group of about twenty colorectal surgeons that brought many complex patient cases that were discussed in a lovely downtown Auckland restaurant. It was a fun evening among colleagues in which I was warmly received. During this discussion, I learned that many colorectal surgeons in Australia and New Zealand perform all aspects of an exenteration, including the cystectomy with the ileal conduit and the closure of large perineal defect with flaps.

Additionally, I was informed that the Australasian colorectal fellowship training is longer than it is in the United States, with two clinical fellowship years in either Australia and /or

 

New Zealand and one year spent abroad- usually in the States. The number of trainees entering and graduating from the fellowship is tightly controlled. This longer training allows exposure and training related to operations such cystectomies and reconstruction that in the US are not included in the formal colorectal residency training.

The following day was spent at Middlemore Hospital, where I presented at Grand Rounds and had the opportunity to speak with physicians that are the current CMO and CEO of the hospital. We discussed funding streams and overall state of healthcare in New Zealand.

New Zealand has a free public health care system and every public hospital, like Middlemore, receives capped support from the government based on prior years’ budgets. Middlemore is the hospital that serves a high percentage of the indigenous (Māori) population and has strived to diversify its workforce to meet the needs of the population. Social determinants of health are not currently a factor in determining the allocation of public funds to hospital budgets. This is routinely brought up by many physician leaders and there is advocacy to bring this change to the system. After Grand Rounds, I was touched when the Middlemore surgical faculty presented me with a beautiful pounamu stone to protect me and bring me prosperity.

While in New Zealand, my family and I had the opportunity to take a whale/dolphin- watching excursion, experience the hot springs in Rotorua and the Geothermal Valley, walk on the white sand of Waipu Beach, and hike around the beautiful Whangarei Falls. Before our departure, when plans to attend a rugby match were upended, Dr Weston’s family invited us to observe a private practice of the “Blues” (one of Auckland’s premier rugby teams) – including the opportunity for my son to throw and kick with some very generous players.

There is no perfect health care system. My travels emphasized that the challenges we are facing in healthcare are global and no one policy nor one government or private sector provider will solve our challenges. However, it also taught me that there is a lot to learn from each other. I am eternally grateful for this remarkable opportunity; it has been one of the highlights of my surgical career to date. I want to thank my partners who took care of my patients while I was gone, as well as my chair Ken Azarow and colleague John Hunter for their continued sponsorship.

 

Family picture with Professor Rowan Parks

Family picture at St Andrews golf course

James the IV portrait

At Arthur’s seat at Edinburgh

With Farhat Din & Danielle Collins at Western Hospital

2024 – Colin Martin

It is an honor and privilege to have received the James IV Travelling Fellowship award. Because of the COVID-19 Pandemic, I had to delay travel until July of 2022. I used the funds to travel to visit Great Ormand Street Children’s Hospital in London England. Next, I attended Birmingham, UK and participated in the 2022 British Association of Pediatric Surgery (BAPS) meeting from July 13th-15th 2022. The final stop of the trip was to visit Edinburgh Scotland hosted by Professor Steve Wigmore.

Visit to Great Ormand Street Hospital (GOSH). I had an opportunity to visit one of the most iconic and historic Children’s Hospital in the world. Since its formation in 1852, the hospital has been dedicated to children’s healthcare. GOSH receives 242,694 outpatient visits and 42,112 inpatient visits every year. My visit was hosted by Paolo De Coppi. Dr. De Coppi is a Consultant Pediatric Surgeon at GOSH, Head of Stem Cells and Regenerative Medicine at the UCL Institute of Child Health in London. I had a chance to tour the clinical wards in the hospital. It was very interesting to tour and visit the neonatal intensive care unit. It was large with several babies with necrotizing enterocolitis and intestinal failure. I have clinical expertise with both of these conditions which lead to very nice bi-directional exchange on the differences in surgical care between our two countries. Finally I had a chance to give a scientific talk to the entire Department of Surgery on my research and clinical interests. The talk was titled “Environmental Stress and Intestinal Development.” It was well received.

 

British Association of Pediatric Surgery (BAPS) Program Highlights: BAPS was established in 1953 with a mission to raise standards in pediatric surgery through education and research. The meeting in Birmingham, UK was the 68th meeting. It was a fantastic to attend. It was similar to other US and international meetings that I have attended in the past. There was a robust scientific program with invited lectures, as well as ample opportunities for social networking. One difference with this program were the snacks and refreshments after each session. By the end of the meeting, I developed an affinity for tea with milk! The program started with a welcome and opening remarks by the BAPS President Munther Haddad. This was then followed by the Prize Session. This is analogous to a plenary session with long talks given by the top abstracts submitted to the program. There was a mix of basic science and clinical topics. There were 10 talks in the session and my favorite was titled: Common Dendritic Progenitors are Responsible for Tolerance Induction Following in Utero Transplantation. This talk was given by Joseph Davidson with mentorship from Great Ormand Street Children’s Hospital and the Children’s Hospital of Philadelphia. The basic science was presented concisely with tangible clinical relevance. There was also a session dedicated to Urology. In the UK many of the pediatric surgeons have extensive urology training and incorporate this into their practice. This is quite unique in the United States and I learned a lot from this session. There was also a research breakout session that focused on conducting qualitative and quantitative research. The topics and speakers were: Dr Beth Deja (University of Liverpool) – Qualitative research – What? Why? and How? Professor Kerry Woolfell (University of Liverpool) – Using qualitative research to determine the feasibility of clinical trials Dr Lisa Hinton (University of Cambridge) – Using parent experience as a tool for education, service improvement and understanding outcomes. This was an amazing session. I am starting to do qualitative research and from this session I got a

 

basic understanding of the tools needed to conduct research in this space. The final highlight of the meeting was the Journal of Pediatric Surgery Lecturer Dr. Marc Levit. Dr. Levitt is a Pediatric Surgeon and the Head of Colorectal Surgery at Children’s National Medical Center in the United States. His talk was titled: Patient Driven Change; Is collaborative care the future of medicine? (Lessons learned from the care of children with colorectal problems). Dr. Levitt gave a compelling talk on his internationally renowned colorectal program. Dr. Levitt was one of my mentors during residency at the University of Cincinnati. I had a chance to reconnect and have lunch with him. It was great to catch up and he gave me good mentoring advice.

 

Visit of Birmingham Children’s Hospital. I had a chance to visit Birmingham Children’s Hospital in the UK. The tour was given by Dr. Suren Arul who is the Division Chief of Pediatric Surgery and Urology. He spoke about the history of the hospital as well as gave us a tour of the hospital including the many new renovations and state of the art equipment. Birmingham Children’s is also the national referral center for liver transplantation. Hearing about the program and clinical volume was very impressive. We also toured the operating rooms and the neonatal and pediatric intensive care units.

 

Edinburgh Scotland. The final stop on our trip was a visit to Edinburgh hosted by Professor Steve Wigmore who is the head of the Hepatobiliary-Pancreatic Surgical Services and Edinburgh Transplant Unit Royal Infirmary of Edinburgh. The Royal Infirmary of Edinburgh and Professor Wigmore have hosted several James IV visit which added an additional value to the visit. I spent 3 days visiting this hospital, round with the team, and observing a few operative cases. Finally I had a chance to visit the surgeons Museum. Surgeons’ Hall Museums is an award winning Museum that is home to one of the largest and most historic pathology collections in the United Kingdom. The Museums are currently home to an extensive collection of pathology, anatomy and medical memorabilia. There was an extensive display surgical history and artifacts dating back hundreds of years. It was quite fascinating.

Again, thank you for this opportunity. It was certainly the highlight of my career! Best,

Colin A. Martin, MD

Brad and Barbara Warner Endowed Professor of Surgery Division Chief, Pediatric Surgery

Washington University in Saint Louis

Surgeon-in-Chief, St. Louis Children’s Hospital

Dr. Marc Levitt at the BAPS meeting


Hospital Chapel
Children’s Hospital in Birmingham


Tour of the Operating Room by Dr. Arul Children’s Hospital in Birmingham


Stained glass window from the Children’s Hospital in Birmingham


Great Ormand Street Hospital Entrance


Hospital Entrance Children’s Hospital in Birmingham


Surgeons Hall Museum Scotland


With Professor Wigmore at Dinner


Edenborough Scotland

2022-2023 – Dung Nguyen

James IV traveling fellowship 2022-23

Dung Nguyen

April 2022

CANADA

Mcmaster university & hamilton health sciences

The COVID19 pandemic has affected all our lives across the globe. It seemed so long ago that I had travelled abroad. My travel plans for James IV were delayed for 2 years due to the pandemic. Needless to say, I was excited to resume global travels. I am a plastic and reconstructive microsurgeon. The goal of my fellowship was to learn how breast reconstruction and lymphedema are being managed across the world and to establish opportunities for collaboration.

My first visit was to McMaster University in Hamilton, Ontario. I landed in Toronto at 3pm and was picked up by the limousine service to take me to where I would be staying at The Barracks Inn. Immediately, I was taken in by the Inn’s timeless, understated elegant décor and warm Ancaster hospitality. Shortly after, I was greeted by my host, Dr. Susan Reid, Professor of Surgery and Immediate-Past Chair of the Department of Surgery at McMaster University. We went to dinner at Ancaster Mill, a creekside restaurant overlooking the falls! The delicious food was a perfect complement to the beautiful scenery and wonderful company. Dr. Reid gave me an overview of Hamilton and the itinerary for the week. I was excited for the busy week ahead. I was back at the Inn at 9pm. By then, I was struggling to stay awake and was ready for good sleep.

The following morning, I was taken to the Juravinski Hospital & Cancer Center where I observed Drs. Chris Coroneos and Ronen Avram performed a delayed-immediate tissue expander to free DIEP flap reconstruction. I saw an effective way to dissect a perforator flap using a monopolar bovie! I had an animated discussion with the surgeons on the differences between the US and Canadian healthcare. Canadians have quicker access to emergency care and do not have to pay for copays and deductibles, but they pay much higher taxes and have limited access and longer wait times to see specialists. In fact, lymphedema surgery is currently not an approved covered benefit. One of the plastic surgeons is trained in lymphatic surgery but has not been able to offer treatment to the patients. This became an area of interest of mine to better understand the barriers and ways that our institutions can collaborate to advocate for better access to healthcare.

That evening, I had another stimulating discussion at dinner with Dr. Reid and two other fantastic women surgeons, Dr. Lua Eiriksson and Dr. Clare Reade, who are trailblazers for changes within their institution to improve work-life balance conditions for women physicians. It was such a wonderful evening and we truly enjoyed ourselves. The conversations were motivating, inspiring, and uplifting. The food at Victoria’s Restaurant was delicious and the atmosphere so relaxing. It was incredible to talk about ideas for research, advances in patient care, international work, leadership and mentorship, the challenges and sacrifices of being a surgeon and raising a family and so on. It was a perfect way to end the first day!

I spent the second day with the residents at McMaster University. I gave a lecture to the residents on breast reconstruction and then went over case discussions. I was impressed by the thoughtful questions from the residents! Dr. Reid then gave me a tour of the University and history of the medical school and the world-famous problem-based learning model. I was impressed by the rich history and beautiful architecture. This was followed by a walk along the Hamilton Waterfront Trail where one overlook Lake Ontario and can see the old steel plant in the distance. In the afternoon, I had the opportunity to visit Synaptive Medical in Toronto. I met with the CEO and got to tour their manufacturing plant and played with their latest version of the 3D exoscope! We had dinner at a fantastic Italian restaurant in downtown before I headed back to Hamilton.

The highlight my third day was giving Grand Rounds to the Division of Plastic & Reconstructive Surgery on “Surgical Advances in Lymphedema Prevention and Treatment”. Lymphedema treatment and prevention is currently not offered in Hamilton, there was interests from within the Plastics Division as well as from vascular surgeons and oncologists to know more about current research and advancement in the field. After Grand Rounds, I returned to the OR at Juravinski Hospital to observe a combined oncoplastic reduction case and additional breast cases. I had an engaging discussion with the breast surgeon, Dr. Nicole Hodgson, on her approaches to nipple sparing mastectomy and axillary lymph node dissection. The day concluded with a nice dinner with the Plastic Surgery faculty and residents.

The next two days was partly spent in the operating room and meeting key administrators. I had the opportunity to meet with Neil Johnson, Vice President, Oncology & Regional VP of Ontario Health for HNHBB Regional Cancer Program. It was great to share our personal journeys and shared pharmacy heritage. He gave me an overview of the Ontario cancer system. We recognized that despite the differences in healthcare systems, we share a lot of similar health constraints and access issues across the border. We concluded our exchange with an invitation to keep in touch and a desire to build future research and education collaboration. I also met Dr. Jonathan Sussman, professor of oncology and Chair of the Department of Oncology at McMaster University. I gained new perspectives on the application of radiation therapy in the treatment of breast cancer. He was interested to know about my experience with lymphaticovenous bypass for prevention of lymphedema after ALND. I find these conversations very stimulating and refreshing!

On my last day, Dr. Reid took me to see Niagra Falls and gave me a car-ride tour of Niagara-on-the-Lake. Niagra Falls is as impressive and majestic as what I have read. Niagara-on-the-Lake is such a lovely town in Southern Ontario with lush wineries that rival Napa Valley, streets that are tree-lined and flower-filled and has the charms of an old town with historical buildings and fine foods. We ended the evening at dinner with the breast and plastics colleagues. I had a wonderful time in during this trip! The inspiring conversations and the friendships I have established are invaluable!

SEPTEMBER 2022

LONDON

IMPERIAL COLLEGE LONDON

My next stop was at the Imperial College London. My sponsor was Professor Ara Darzi, Baron Darzi of Denham, and the Paul Hamlyn Chair of Surgery at the Imperial College London, the Royal Marsden Hospital, and the Institute of Cancer Research. My host was breast surgical oncologist, Daniel Leff. It was such an honor for me to meet Professor Darzi and learned about his inspiring medical and political career and his passion in global health and innovation. I was grateful for his invaluable advice on career growth and development.

Upon arrival at the Charing Cross Hospital, Dr. Leff introduced me to his breast colleague, Dr. Michael Boland, and the plastic surgery team, including Drs. Simon Wood, Frank Henry, and Georgina Williams. On my first day, I observed a HoloLens-Assisted DIEP flap for breast reconstruction. Dr. Henry introduced me to the HoloLens which is a holographic augmented reality imaging technology to map out the perforators for DIEP flap harvest. At our institution, we use 3D models of the perforators to plan our flap dissection, so it was very interesting for me to see another way of using 3D technology to guide surgical dissection. I also saw an oncoplastic surgery by the breast team and had an engaging discussion about the timing of radiation therapy and shared our experience and thoughts about the pros and cons of radiation therapy before or after mastectomy on oncologic and aesthetic outcomes.

During my visit, I saw many great cases, including nipple sparing mastectomy and immediate direct-to-implant reconstruction with mesh by Dr. Hogben. I was impressed by how proficient the breast surgical oncologists are at performing oncoplastic surgery, including local perforator flap for lumpectomy reconstruction.

For my Grand Rounds, I gave a talk on our novel technique of breast reconstruction using the omentum fat-augmented free flap which generated a lot of great discussion and interests. I also learned that we share a common interest in lymphedema prevention surgery. Dr. Paul Thiruchelvam shared their preliminary data on the LYMPHA procedure, and we saw an opportunity to collaborate!

A major attraction during my visit was the tour of the Hamlyn Center and Institute of Global Health Innovation. The center is an impressive facility that focuses on technological innovation in imaging, sensing, and robotics with a strong emphasis on clinical translation to address global health challenges. I had the privilege of meeting the staff of the Hamlyn center and learning about the exciting projects that are underway including Mammobot and imaging technology to visualize cancer intraoperatively. The integrated and comprehensive research laboratories and teaching facilities were just amazing to see! It was great to end my visit on such a high note!

LONDON breast meeting 2022

Before leaving London, I attended the London Breast Meeting where I spoke on lymphedema and breast reconstruction panels and met up with colleagues from around the world. I also witnessed the historical moment when the country learned about the passing of Queen Elizabeth II. Within hours, the entire country was in mourning. Some of us took a break from the conference to pay our respects to the Queen at Buckingham Palace.

Austria

whitlinger lymphedema clinic

Before returning to the States, I visited the Wittlinger Lymphedema Clinic in Austria. The clinic has been in existence for more than 50 years and is internationally known as Europe’s center for excellence in holistic lymphedema management. It is a facility that offers comprehensive conservative lymphedema management where patients check in for 2-3 weeks at a time and receive complete medical workup, daily physiotherapy, aquatic exercise, nutrition consultation, garment fitting, and skin/nail treatments. It is also the founding site of the famous Vodder technique of manual lymphatic drainage. I got to experience the treatments as a patient for 3 days and saw the effectiveness of good conservative therapy. Inspired by what I saw, we are adopting some of their treatment approaches in a program that is tailored for patients undergoing surgery to maximize volume reduction after surgery.

March 2023

Malaysia

university of malaya kuala lumpur

My last destination was Asia where I visited Professor April Camilla Roslani, Dean of the Faculty of Medicine, and the Department of Surgery at the University of Malaya. I was excited to meet Dr. Roslani, a woman leader and pioneer who is leading the largest colorectal cancer treatment center in the country and who has paved the way to improve working conditions for women in medicine and advancing surgical standards within her country. It was enlightening to get her perspective and advice on mentorship and leadership development.

At the hospital, I saw complex breast and lower extremity reconstruction with free tissue transfer by plastic surgeons using loupe microsurgery. Just as in London, the breast surgeons are very proficient at doing implant-based reconstruction and pedicled flaps, including TRAM flap.

Dr. Hoong gave me a tour of the Breast Cancer Resource Center. She shared her vision of developing an integrated Breast Oncoplastic Curriculum Module to train future breast surgeons in providing basic reconstructive procedures to increase patients’ access to breast reconstruction.

I attended radiology rounds and breast and plastic clinics during my visit. I learned that access to lymphedema treatment is still limited in Malaysia. For Grand Rounds, I gave a lecture on lymphedema management to the residents and faculty. We discussed about our lymphedema prevention clinical trial at Stanford and had discussions on how to offer a similar service to breast cancer patients there.

Lecture on Lymphedema Management

During my visit, I also learned about the Silent Mentor Program, a voluntary body donation program for medication education, training, and research. I was fascinated to learn about the origin of the program in Taiwan and how it was adopted in Malaysia. It is a very interesting program that merges professional medical training with humanistic appreciation in a way that teaches students to respect and show gratitude to the body donor who becomes their silent mentor.

Of course, one cannot leave Malaysia without appreciating its delicious cuisine! Malaysian food, as I learned, is a melting pot of different ethnic foods. It is highly varied in flavors with unique blend of Chinese, Indian, Thai, and even a hint of European influence!

VIETNAM

medical mission trip in hue

Finally, from Malaysia I flew to Hue, Vietnam where I wrapped up the year of traveling with a medical mission trip with ReSurge International to teach and provide breast reconstruction and lymphedema surgeries. There, I also had the opportunity to share my travel experience with local surgeons.

Overall, my James IV travelling fellowship has been extremely rewarding, educational and eye-opening. I appreciate seeing how breast reconstruction and lymphedema are being managed across the globe. I have made many new colleagues and friends and am excited to continue to cultivate these relationships and nurture opportunities for collaboration.

2022-2023 – Jin He

Jin He, MD, PhD, FACS

Chief, Division of HPB Surgery

Paul K. Neumann Professorship in Pancreatic Surgery

Associate Professor of Surgery and Oncology

James IV Association of Surgeons US Traveler 2022-2023

Check out my pictures here!

European Travels:

• October 16th to October 29th 2022

• May 23rd to June 2nd 2023

 

It is a tremendous honor and privilege to receive this traveling fellowship. I am very grateful to

the James IV Association for this superb opportunity.

As an HPB surgeon with research focusing on pancreatic surgery, I hope to gain insight and a

better understanding of how our European colleagues manage patients with pancreatic

diseases. Therefore, I chose four world-renowned institutions in pancreatic surgery with the

goal of sharing surgical experiences, consolidating existing relationships, and cultivating new

collaborations during my visit.

 

Part 1: University Hospital, University of Heidelberg

Heidelberg is a scientific hub in Germany and home to several internationally renowned

research facilities adjacent to University of Heidelberg, the oldest German university, including

the European Molecular Biology Laboratory (EMBL), Max Planck Institutes, and DKFZ. I visited

Prof. Markus Büchler at the University Hospital Heidelberg, the leading world-renowned

Hepato-Pancreato-Biliary surgery program in the EU. Prof. Büchler is an extremely busy person

who has numerous responsibilities at the departmental, institutional, national, and

international levels. He loves to operate. I was lucky to observe him perform two operations.

One is a large RP sarcoma, which was deemed unresectable at other hospitals. Prof. Büchler

demonstrated his surgical talents and knowledge during this complex multi-organ resection and

multiple vessel reconstructions. He must have been exhausted when he finished the IVC

reconstruction. Different from the US system, the Heidelberg surgeon stands on the right side

of the table. The assisting surgeon on the left side of the table is only responsible for exposure

without knot tying or suturing. Prof. Büchler is very supportive of robotic pancreatectomy. As a

world-renowned senior surgeon, he is never against any new technology in the surgery field. I

witnessed his robotic distal pancreatectomy and had a lovely discussion with him about robotic

pancreas surgery.

Heidelberg program has the largest HPB volume in Europe, with around 700 pancreas surgery

cases per year. The HPB team has multiple experienced surgeons and at least 5 operating

rooms per day. I enjoyed interacting with all of them in the OR, ICU, daily morning sign-out and

evening conferences led by Prof. Martin Schneider, the acting director for the daily activity of

the whole department. I had a lovely German dinner with Prof. Martin Loos, who leads the

robotic pancreatectomy program. Dr. Felix Nickel gave me a tour of the MIS simulation lab at

the University. He is very excited about in applying biotissue and AI to facilitate training in MIS

HPB surgery. He is leaving with Prof. Thilo Hackert, the director of the European Pancreas

Center, who is heading to the University of Hamburg as the new department chair. I also

observed open pancreas surgeries by Professor Beat Müller (the current chair of surgery at the

University of Basel, Switzerland) and Prof. Arianeb Mehrabi, who is also in charge of the liver

transplant program.

I shared my practice and program building in robotic pancreatectomy during my grand round to

the Department of General, Visceral and Transplantation Surgery.

My local host, Dr. Benedict Kinny-Koster, took me for a walk on the Karl Theodor Bridge,

commonly known as the Old Bridge (Alte Brücke), crossing the Neckar river. He and I meet daily

to discuss research projects and career development while enjoying German food and beer.

Part 2: Amsterdam UMC, University of Amsterdam

After a memorable week at Heidelberg, I boarded the train from Frankfurt to Amsterdam.

I met Prof. Marc Besselink for the morning sign-out meeting and ward round before going to

the operating room. The pancreas surgery program led by Prof. Marc Besselink at Amsterdam

UMC has contributed numerous clinical trials in pancreatology. I observed their robotic

Whipple, which used a two-surgeons model. Marc and Dr. Olivier Busch did the case with Marc

at the bedside to assist and dissect during the resection phase. After the Whipple specimen was

removed, the team took a 15-minute lunch break. Marc switched to the console for the

reconstruction of PJ and HJ. The gastrojejunostomy was done in an extracorporeal fashion. I

shared my experience with robotic pancreatectomy and convinced Marc to switch to an

intracorporeal gastrojejunostomy. I am glad my surgery videos helped convince Marc.

Marc also took me to the pancreas multidisciplinary discussion. I was blown away by witnessing

numerous ongoing clinical trials in surgery, medical oncology, radiation oncology,

gastroenterology, pain service, etc. Every single patient was on multiple clinical trials. I enjoyed

the discussion on managing patients with pancreatic cancer and shared my experience at JHH.

Marc gave me a tour of the research facility with more than 30 PhD students and fellows

working on those clinical studies under his leadership. This incredible setup and relentless

teamwork are why the AMC is such an effective academic powerhouse.

I also joined the weekly Zoom discussion of LAPC management organized by the Dutch

Pancreatic Cancer Group, which has achieved many milestone studies across the entire

spectrum of pancreatic cancer. Marc, with his boundless energy, is instrumental in this process.

I am sure the numerous coffee machines across the campus contribute to the team’s energy.

And the coffee is free.

 

Part 3: University of Glasgow

The second leg of my traveling in 2023 started at the University of Glasgow. I flew from BWI to

Heathrow and arrived in Glasgow on May 23rd. My local hosts, Prof. David Chang and Prof. Nigel

Jamieson had arranged a wonderful itinerary for me to interact with their clinical team and

research group.

With David’s company, I joined the weekly multidisciplinary pancreas case discussions and

toured their inpatient ward. I observed the open Whipple done by Mr. Euan Dickson. Euan was

the James IV traveler in 2019 and visited Johns Hopkins. We had lovely discussions in his

operating theater. The robotic pancreas surgery has not been widely adopted in the operating

theater at Glasgow. I shared my experience on robotic pancreatectomy during my grand round

to the Lister Department of Surgery at the Glasgow Royal Infirmary.

Under the leadership of Prof. Andrew Biankin, David has built up a very productive research

enterprise on Precision Medicine for Pancreatic Cancer. He is leading the national Precision-

Panc study across the UK. We toured his lab at the Wolfson Wohl Cancer Research Centre of

the University of Glasgow. I enjoyed the presentations from his lab members and the casual

group dinner afterward.

Nigel gave me a tour of the historic Glasgow Royal Infirmary and its beautiful surroundings. He

also arranged the dinner with the whole group of surgery faculties at the amazing Royal College

of Physicians and Surgeons of Glasgow. Having a dinner in this historic place with a group of

Glasgow surgeons was absolutely a highlight of this trip. I indulged myself to the tremendous

surgical history and was excited to read about those achievements with portraits of Prof. Lister,

Prof. Pringle, etc. I had a wonderful discussion on pancreatic cancer with two other James IV

travelers: Prof. David Chang and Mr. Euan Dickson.

 

Part 4: University of Verona

I left Glasgow and boarded the flight to my final visiting site, the Pancreas Institute at the ‘G.B.

Rossi’ Hospital, University of Verona. The Pancreas Institute is the first Italian institution entirely

committed to pancreatic diseases, with a dedicated multidisciplinary team that includes

Surgeons, Gastroenterologists, Radiologists, Pathologists, and Medical Oncologists.

I hoped to meet Prof. Claudio Bassi, the founder of the Pancreas Institute. Unfortunately, he

was in the ICU and passed away on July 11th, 2023. Prof. Bassi was a true giant of pancreas

surgery. This is a huge loss to the international pancreas community.

My local host is Prof. Giuseppe Malleo, whom I have known for years. Giuseppe and Dr. Antonio

Pea took me to their morning sign-out. I met their resident team and participated in their

Pancreas Round, a preoperative conference to review scheduled cases for next week. I really

enjoyed the meeting with all the young trainees and delivered a grand round at the Pancreas

Institute. They asked many great questions during my talk on robotic pancreatectomy.

I also met Prof. Claudio Luchini, a pancreas pathologist, who has been a wonderful collaborator

with the Johns Hopkins pancreas group.

The operating room setup was unique as they are on two different campuses. Robotic surgery

was only adopted for distal pancreatectomy. The Verona group plans to adopt the robotic

approach in Whipple surgery once the operating rooms are unified into one campus.

I had a unique opportunity to pay a one-day visit to the pancreas program at the University of

Padua with Prof. Giovanni Marchegiani. He left University of Verona and took a new leadership

role at Padua very recently. University of Padua is only 40 minutes away from Verona by train.

It is the second-oldest university in Italy. The tremendous history of this city blew me away.

During the farewell dinner, I was super grateful to Prof. Roberto Salvia, the current director of

the Pancreas Institute, who joined us directly from the airport after returning from a national

meeting.

 

Final thoughts:

I want to thank the James IV Association of Surgeons for giving me this opportunity, which has

been one of the highlights of my surgical career. I thank all my host surgeons who created

amazing itineraries and showed me their home programs.

I thank Dr. Cameron and Dr. Higgins for sponsoring me, my partners in JHH HPB Surgery for

covering emergencies, and my wife’s support during my extended absences.

Without question, these traveling experiences afforded by the James IV Traveling fellowship

have opened my mind and further fostered research collaborations. The opportunity to be a

James IV traveling fellow will influence me forever.